| Date | Form | Description | Docs | XBRL | Pages |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/19/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
56 | |
| 06/19/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
124 | |
| 06/19/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 06/14/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 06/14/13 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 06/14/13 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
16 | |
| 06/11/13 | UPLOAD | SEC-generated letter |
|
1 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...